A real-life study of the effectiveness of different pharmacological approaches to the treatment of smoking cessation: re-discussing the predictors of success
Carregando...
Citações na Scopus
15
Tipo de produção
article
Data de publicação
2011
Título da Revista
ISSN da Revista
Título do Volume
Editora
HOSPITAL CLINICAS, UNIV SAO PAULO
Autores
Citação
CLINICS, v.66, n.1, p.65-71, 2011
Resumo
OBJECTIVE: To evaluate the effectiveness of nicotine replacement therapy (NRT), bupropion, nortriptyline and combination therapy and describe factors associated with treatment success. INTRODUCTION: Clinical trials clearly demonstrate the efficacy of pharmacotherapy in smoking cessation. However, it is only after its use in real-life settings that clinical effectiveness and limitations of a treatment are fully known. METHODS: Patients attended a four-session cognitive-behavioral program and received medicines free of charge. Abstinence from smoking was assessed at each visit. RESULTS: A total of 868 smokers (68.8% women) were included. Their mean age was 49.6 years; the amount smoked was 25 cigarettes/day and the Fagerstrom Score was 6.6. Abstinence rates after 6 months and 1 year were 36.5% and 33.6%. In univariate analysis, male gender, age (> 50), higher number of cigarettes smoked, cardiovascular comorbidities, longer interval from the last cigarette and combined treatment of nortriptyline plus NRT were predictive of abstinence, while neuropsychiatric comorbidities and the answer ""yes'' to the question ""Do you smoke more often during the first hours after waking'' were correlated with failure. In a multivariate model, predictors of abstinence were neuropsychiatric comorbidities, the answer ""yes'' to the question ""Do you smoke more often during the first hours after waking'' and combined treatment of nortriptyline plus NRT. Male gender and a longer period from the last cigarette were correlated with lower abstinence rate. CONCLUSION: Satisfactory success rates were obtained in a teaching hospital. Factors such as age, daily cigarette consumption, number of pack-years and dependency score were not reliable markers of abstinence. The combination nortriptyline+NRT was independently associated with higher abstinence rates.
Palavras-chave
General practice, Nortriptyline, Cognitive-behavioral, Combined therapy, Weight gain
Referências
- American Psychiatric Association, 1994, DIAGN STAT MAN MENT
- Nides M, 2006, ARCH INTERN MED, V166, P1561, DOI 10.1001/archinte.166.15.1561
- Hays JT, 2001, ANN INTERN MED, V135, P423
- Perkins KA, 2008, NICOTINE TOB RES, V10, P1245, DOI 10.1080/14622200802097506
- Zhu SH, 2000, AM J PREV MED, V18, P305, DOI 10.1016/S0749-3797(00)00124-0
- Gonzales D, 2006, JAMA-J AM MED ASSOC, V296, P47, DOI 10.1001/jama.296.1.47
- WILLIAMSON DF, 1991, NEW ENGL J MED, V324, P739, DOI 10.1056/NEJM199103143241106
- Munafo M, 2004, NICOTINE TOB RES, V6, P769, DOI 10.1080/1462200410001696556
- Haggstram FM, 2006, PULM PHARMACOL THER, V19, P205, DOI 10.1016/j.pupt.2005.05.003
- Hajek P, 1999, ARCH INTERN MED, V159, P2033, DOI 10.1001/archinte.159.17.2033
- Prochazka AV, 1998, ARCH INTERN MED, V158, P2035, DOI 10.1001/archinte.158.18.2035
- Jorenby DE, 1999, NEW ENGL J MED, V340, P685, DOI 10.1056/NEJM199903043400903
- Klesges RC, 1997, J CONSULT CLIN PSYCH, V65, P286, DOI 10.1037//0022-006X.65.2.286
- Aveyard P, 2008, BRIT MED J, V336, P1223, DOI 10.1136/bmj.39545.852616.BE
- Aveyard P, 2007, BRIT MED J, V335, P37, DOI 10.1136/bmj.39252.591806.47
- Costa CL, 2002, CHEST, V122, P403
- Fiore M. C., 2008, TREATING TOBACCO USE
- Frieden TR, 2007, LANCET, V369, P1758, DOI 10.1016/S0140-6736(07)60782-X
- Menezes AM, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-151
- Prochazka AV, 2004, ARCH INTERN MED, V164, P2229, DOI 10.1001/archinte.164.20.2229
- Stead LF, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000146.pub3
- Wagena EJ, 2005, ADDICTION, V100, P317, DOI 10.1111/j.1360-0443.2005.00998.x